FindTrial
Sign In

JARDIANCE 25mg

DRUG2 trials

Sponsors

Boehringer Ingelheim, Odense University Hospital

Conditions

Diabetes Mellitus, Type 2Kidney Transplantation RecipientsMagnetic Resonance Imaging (MRI)Non-Diabetic PatientsPlacebo Control DesignRandomized Controlled TrialSodium-Glucose Transporter 2 Inhibitors

Phase 4

Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
Active, not recruitingNCT06933355
Odense University HospitalKidney Transplantation Recipients, Magnetic Resonance Imaging (MRI), Non-Diabetic Patients +3
Start: 2025-03-27End: 2026-06-01Target: 8Updated: 2025-07-31

Unknown Phase

JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
CompletedNCT02848833
Boehringer IngelheimDiabetes Mellitus, Type 2
Start: 2016-08-10End: 2020-04-17Updated: 2021-05-11

Related Papers

SGL-TX-MR-study protocol acute effects of SGLT2 inhibitor on kidney allograft oxygen tension, a randomized, double-blind, placebo controlled crossover trial.
2025-12-29